Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD3043

NCT00918515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD3043

Sponsor

AstraZeneca